Wishing I topped up below $1.20 but already too overweight CL1 so didn't. Will just enjoy the ride back up to re-rate where we should be.If anyone went to the class connect conference last night, would love to hear thoughts?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%